BELLUS Health Inc. (TSE:BLU – Get Free Report) passed below its 50 day moving average during trading on Tuesday . The stock has a 50 day moving average of C$19.48 and traded as low as C$19.24. BELLUS Health shares last traded at C$19.48, with a volume of 28,666 shares.
BELLUS Health Trading Down 0.1 %
The stock has a market cap of C$2.47 billion, a P/E ratio of -20.29 and a beta of -0.28. The company has a debt-to-equity ratio of 0.32, a current ratio of 33.42 and a quick ratio of 16.40. The business’s fifty day simple moving average is C$19.48.
About BELLUS Health
BELLUS Health Inc, a clinical-stage biopharmaceutical company, develops therapeutics for the treatment of refractory chronic cough (RCC) and other cough hypersensitivity indications. Its lead product candidate includes BLU-5937, an antagonist of the P2X3 receptor, which is in Phase II clinical trial for treatment of RCC and chronic pruritus.
Recommended Stories
- Five stocks we like better than BELLUS Health
- Dividend Payout Ratio Calculator
- 3 Small Cap Stocks That Insiders Are Buying
- Most Volatile Stocks, What Investors Need to Know
- Analysts Forecast Big Upside for Western Digital—Don’t Miss Out
- 3 Home Improvement Stocks that Can Upgrade Your Portfolio
- 3 Must-Own Stocks for Bullish Investors in Today’s Market
Receive News & Ratings for BELLUS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BELLUS Health and related companies with MarketBeat.com's FREE daily email newsletter.
